Coherus BioSciences, Inc.

Go to Coherus BioSciences, Inc. Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$249.0 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, a...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Coherus BioSciences (CHRS) delivered earnings and revenue surprises of -540% and 24.45%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: CHRS, RNA.

Read Full Article

– Net revenue of $77.1 million in Q1 2024 –

Related tickers: CHRS.

Read Full Article
Trending Tickers
ITOS

XNAS

$0.00
(%)
MIMO

XASE

$0.00
(%)
PRSO

XNAS

$0.00
(%)
QQQ

XNAS

$0.00
(%)
$0.00
(%)